Rizatriptan Benzoate

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

37 API Suppliers, 21 USDMF, 13 CEP/COS, 4 JDMF, 15 EU WC, 13 NDC API, 23 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

30 Drugs in Development

30 Drugs in Development

INTERMEDIATES

13 Intermediate Suppliers

13 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

343 FDF Dossiers, 55 FDA Orange Book, 196 Europe, 41 Canada, 7 Australia, 17 South Africa, 27 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FILM;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 10MG BASE, TABLET;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 10MG BASE, TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 6 Rochem International Inc, 19 SPI Pharma, 7 DKSH, 1 Pharm-RX Chemical, 4 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 2 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 2 Kirsch Pharma, 4 ACG Worldwide, 3 Actylis, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Ashland, 6 BASF, 1 Bioplus Life Sciences, 11 Corel Pharma Chem, 6 DFE Pharma, 9 Gangwal Chemicals, 4 Ideal Cures, 5 Ingredion Pharma Solutions, 20 Kerry, 4 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 13 Microlex e.U, 3 Nitika Pharmaceutical Specialities, 2 Novo Excipients, 4 Pharmatrans-Sanaq, 6 Pluviaendo, 5 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 7 Seppic, 6 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 4 Silverline Chemicals, 1 Symrise, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 4 Vasa Pharmachem, 2 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

71 Fillers, Diluents & Binders, 46 Disintegrants & Superdisintegrants, 42 Coating Systems & Additives, 34 Direct Compression, 28 Taste Masking, 26 Granulation, 24 Chewable & Orodispersible Aids, 22 Thickeners and Stabilizers, 17 Controlled & Modified Release, 17 Lubricants & Glidants, 16 Film Formers & Plasticizers, 12 Co-Processed Excipients, 11 Parenteral, 9 Empty Capsules, 5 Solubilizers, 5 Rheology Modifiers, 4 Emulsifying Agents, 4 Vegetarian Capsules, 4 API Stability Enhancers, 3 Topical, 2 Coloring Agents, 1 Soft Gelatin

DIGITAL CONTENT

1 Stock Recap #PipelineProspector, 19 News #PharmaBuzz

GLOBAL SALES INFORMATION

15 US Medicaid Prescriptions, 101 Regulatory FDF Prices

MARKET PLACE

11 APIs

11 APIs

PATENTS & EXCLUSIVITIES

1 US Patents, 4 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls

Filters

Xls

USFDA APPLICATION NUMBER - 20865 / DOSAGE - TABLET, ORALLY DISINTEGRATING;ORAL - EQ 5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

Ingredient Name	Basis of Strength	Strength
Active Ingredient/Active Moiety
rizatriptan benzoate(UNII: WR978S7QHH) (rizatriptan - UNII:51086HBW8G)	rizatriptan	5mg \| 10mg \| 5mg \| 10mg

Inactive Ingredients

Ingredient Name	Merck Sharp & Dohme Corp.	Par Pharmaceutical Inc.
aspartame(Z0H242BBR1)
CELLULOSE, MICROCRYSTALLINE(OP1R32D61U)
FERRIC OXIDE RED(1K09F3G675)
gelatin(2G86QN327L)
gelatin, unspecified(2G86QN327L)
glycine(TE7660XO1C)
lactose monohydrate(EWQ57Q8I5X)
magnesium stearate(70097M6I30)
mannitol(3OWL53L36A)
MICROCRYSTALLINE CELLULOSE(OP1R32D61U)
STARCH, CORN(O8232NY3SJ)

Setid 6e98aed7 55f8 4ae4 A9d4 58e9d9bae305 Applno 20865 Form Tablet Orally Disintegrating Oral Dosage Eq 5mg Base - Drug Product Composition: Rizatriptan Benzoate